The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Vancomycin resistance in Staphylococcus aureus
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Murdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Control of Communicable Diseases Manual
(2015) · American Public Health Association eBooks · doi:10.2105/ccdm.2745 · Cited by 1,599
The Changing Epidemiology of Staphylococcus aureus?
Chambers, H. F. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010204 · Cited by 1,495
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Gill, S. R., Fouts, D. E., Archer, G. L., Mongodin, E. F., DeBoy, R. T., Ravel, J., Paulsen, I. T., Kolonay, J. F., Brinkac, L., Beanan, M., et al. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2426-2438.2005 · Cited by 1,026
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Holden, M. T. G., Feil, E. J., Lindsay, J. A., Peacock, S. J., Day, N. P. J., Enright, M. C., Foster, T. J., Moore, C. E., Hurst, L., Atkin, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402521101 · Cited by 892
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Klein, E., Smith, D. L., & Laxminarayan, R. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1312.070629 · Cited by 862
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
The evolution of Staphylococcus aureus
Deurenberg, R. H., & Stobberingh, E. E. (2008) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2008.07.007 · Cited by 721
Rapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak
Köser, C. U., Holden, M. T. G., Ellington, M. J., Cartwright, E. J. P., Brown, N. M., Ogilvy-Stuart, A. L., Hsu, L. Y., Chewapreecha, C., Croucher, N. J., Harris, S. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109910 · Cited by 654
Bugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 650
Sieradzki, K., Roberts, R. B., Haber, S. W., & Tomasz, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400704 · Cited by 638
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Klevens, R. M., Edwards, J. R., Tenover, F. C., McDonald, L. C., Horan, T., Gaynes, R., & System, N. N. I. S. (2006) · Clinical Infectious Diseases · doi:10.1086/499367 · Cited by 551
Hasman, H., Saputra, D., Sicheritz-Ponten, T., Lund, O., Svendsen, C. A., Frimodt-Møller, N., & Aarestrup, F. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02452-13 · Cited by 542
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUP
Barna, J. C. J., & Williams, D. H. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.002011 · Cited by 528
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512
Kuroda, M., Kuroda, H., Oshima, T., Takeuchi, F., Mori, H., & Hiramatsu, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03599.x · Cited by 512
Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M.-N., Ploy, M.-C., El Solh, N., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.5-14.2003 · Cited by 492
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Dantes, R. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10423 · Cited by 452
Tenover, F. C., & Moellering, R. C. (2007) · Clinical Infectious Diseases · doi:10.1086/513203 · Cited by 452
Steinkraus, G., White, R., & Friedrich, L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm258 · Cited by 420
de Kraker, M. E. A., Jarlier, V., Monen, J. C. M., Heuer, O. E., van de Sande, N., & Grundmann, H. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12028 · Cited by 385
Charles, P. G. P., Ward, P. B., Johnson, P. D. R., Howden, B. P., & Grayson, M. L. (2004) · Clinical Infectious Diseases · doi:10.1086/381093 · Cited by 384
The Progressive Intercontinental Spread of Methicillin-Resistant Staphylococcus aureus
Ayliffe, G. A. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s74 · Cited by 375
Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.275-280.2004 · Cited by 370
Self-citationINFECTION BY PENICILLIN-RESISTANT STAPHYLOCOCCI
Barber, M., & Rozwadowska-Dowzenko, M. (1948) · The Lancet · doi:10.1016/s0140-6736(48)92166-7 · Cited by 368
Hanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 366
Utsui, Y., & Yokota, T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.397 · Cited by 365
Sakoulas, G., Eliopoulos, G. M., Moellering, R. C., Wennersten, C., Venkataraman, L., Novick, R. P., & Gold, H. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1492-1502.2002 · Cited by 364
Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344
High-level vancomycin-resistant enterococci causing hospital infections
Uttley, A. H. C., George, R. C., Naidoo, J., Woodford, N., Johnson, A. P., Collins, C. H., Morrison, D., Gilfillan, A. J., Fitch, L. E., & Heptonstall, J. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800030478 · Cited by 343
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Périchon, B., & Courvalin, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00346-09 · Cited by 334
Whole genome sequencing in clinical and public health microbiology
Kwong, J. C., Mccallum, N., Sintchenko, V., & Howden, B. P. (2015) · Pathology · doi:10.1097/pat.0000000000000235 · Cited by 328
Utaida, S., Dunman, P. M., Macapagal, D., Murphy, E., Projan, S. J., Singh, V. K., Jayaswal, R. K., & Wilkinson, B. J. (2003) · Microbiology · doi:10.1099/mic.0.26426-0 · Cited by 326
Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2276-2285.2000 · Cited by 318
Weinstein, R. A., & Fridkin, S. K. (2001) · Clinical Infectious Diseases · doi:10.1086/317542 · Cited by 304
Genomic variation and evolution of Staphylococcus aureus
Lindsay, J. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.013 · Cited by 274
Vancomycin-resistant Staphylococcus aureus
Howe, R. A., Bowker, K. E., Walsh, T. R., Feest, T. G., & MacGowan, A. P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78597-4 · Cited by 274
Sieradzki, K., & Tomasz, A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2557-2566.1997 · Cited by 274
Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus
SORRELL, T. C., PACKHAM, D. R., SHANKER, S., FOLDES, M., & MUNRO, R. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-344 · Cited by 260
Vancomycin‐Resistant Enterococci: Mechanisms and Clinical Observations
Gold, H. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321815 · Cited by 258
Robinson, D. A., Kearns, A. M., Holmes, A., Morrison, D., Grundmann, H., Edwards, G., O'Brien, F. G., Tenover, F. C., McDougal, L. K., Monk, A. B., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74814-5 · Cited by 256
Ubukata, K., Nonoguchi, R., Matsuhashi, M., & Konno, M. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.5.2882-2885.1989 · Cited by 247
Herbert, S., Bera, A., Nerz, C., Kraus, D., Peschel, A., Goerke, C., Meehl, M., Cheung, A., & Götz, F. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030102 · Cited by 247
Production of l-DOPA by Aspergillus terreus
Chattopadhyay, S., & Das, A. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03888.x · Cited by 243
Cui, L., Iwamoto, A., Lian, J.-Q., Neoh, H.-M., Maruyama, T., Horikawa, Y., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.428-438.2006 · Cited by 240
Musser, J. M., & Kapur, V (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.8.2058-2063.1992 · Cited by 231
Vancomycin-Resistant Staphylococcus aureus--Pennsylvania, 2002
(2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.17.2116 · Cited by 228
Bozdogan, B. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg457 · Cited by 225
Self-citationHowden, B. P., Johnson, P. D. R., Ward, P. B., Stinear, T. P., & Davies, J. K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00422-06 · Cited by 224
Staphylococcus aureus With Reduced Susceptibility to Vancomycin—United States, 1997
(1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110029014 · Cited by 223
D’Agata, E. M. C., Webb, G. F., Horn, M. A., Moellering, Jr., & Ruan, S. (2009) · Clinical Infectious Diseases · doi:10.1086/595844 · Cited by 218
Meehl, M., Herbert, S., Götz, F., & Cheung, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-07 · Cited by 216
The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus Aureus
Walsh, T. R., & Howe, R. A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160806 · Cited by 215
Next-Generation Sequencing for Infectious Disease Diagnosis and Management
Lefterova, M. I., Suarez, C. J., Banaei, N., & Pinsky, B. A. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.07.004 · Cited by 207
An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
Cui, L., Isii, T., Fukuda, M., Ochiai, T., Neoh, H.-M., Camargo, I. L. B. D. C., Watanabe, Y., Shoji, M., Hishinuma, T., & Hiramatsu, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00437-10 · Cited by 206
Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205
(2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1511 · Cited by 202
McAleese, F., Wu, S. W., Sieradzki, K., Dunman, P., Murphy, E., Projan, S., & Tomasz, A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.3.1120-1133.2006 · Cited by 196
Reynolds, P. E., Depardieu, F., Dutka‐Malen, S., Arthur, M., & Courvalin, P. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00497.x · Cited by 193
Gardete, S., Wu, S. W., Gill, S., & Tomasz, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00356-06 · Cited by 187
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Rossi, F., Diaz, L., Wollam, A., Panesso, D., Zhou, Y., Rincon, S., Narechania, A., Xing, G., Di Gioia, T. S. R., Doi, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303359 · Cited by 182
Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus Endocarditis
Kaatz, G. W., Seo, S. M., Dorman, N. J., & Lerner, S. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.103 · Cited by 166
Rudkin, J. K., Edwards, A. M., Bowden, M. G., Brown, E. L., Pozzi, C., Waters, E. M., Chan, W. C., Williams, P., O’Gara, J. P., & Massey, R. C. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir845 · Cited by 164
Howden, B. P., Stinear, T. P., Allen, D. L., Johnson, P. D. R., Ward, P. B., & Davies, J. K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01613-07 · Cited by 160
Kos, V. N., Desjardins, C. A., Griggs, A. D., Cerqueira, G., van Tonder, A. J., Holden, M. T. G., Godfrey, P. A., Palmer, K. L., Bodi, K. L., Mongodin, E. F., et al. (2012) · mBio · doi:10.1128/mbio.00112-12 · Cited by 155
Nishi, H., Komatsuzawa, H., Fujiwara, T., Holmes, N., & Sugai, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4800-4807.2004 · Cited by 151
Tertiary Structure of Staphylococcus aureus Cell Wall Murein
Dmitriev, B. A., Toukach, F. V., Holst, O., Rietschel, E., & Ehlers, S. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.21.7141-7148.2004 · Cited by 150
Reynolds, P. E., & Brown, D. F. J. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80036-3 · Cited by 148
Jarvis, W. R., Schlosser, J., Chinn, R., Tweeten, S., & Jackson, M. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.009 · Cited by 144
Sieradzki, K., Łęski, T. A., Dick, J. D., Borio, L. L., & Tomasz, A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1687-1693.2003 · Cited by 143
INFECTIONS CAUSED BY A PARTICULAR PHAGE TYPE OF STAPHYLOCOCCUS AUREUS
Rounteee, P. M., & Freeman, B. M. (1955) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1955.tb35001.x · Cited by 142
Gargis, A. S., Kalman, L. V., & Lubin, I. M. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00949-16 · Cited by 140
Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Foucault, M.-L., Courvalin, P. M., & Grillot‐Courvalin, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01702-08 · Cited by 137
Pfeltz, R. F., Singh, V. K., Schmidt, J. L., Batten, M. A., Baranyk, C. S., Nadakavukaren, M. J., Jayaswal, R. K., & Wilkinson, B. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.294-303.2000 · Cited by 134
Zhu, W., Murray, P. R., Huskins, W. C., Jernigan, J. A., McDonald, L. C., Clark, N. C., Anderson, K. F., McDougal, L. K., Hageman, J., Olsen-Rasmussen, M. A., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-10 · Cited by 132
Scherl, A., François, P., Charbonnier, Y., Deshusses, J., Koessler, T., Huyghe, A., Bento, M., Stahl-Zeng, J., Fischer, A., Masselot, A., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-296 · Cited by 131
Moreira, B. M., Boyle‐Vavra, S., DeJonge, B. L. M., & Daum, R. S. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1788 · Cited by 131
Moise, P. A., North, D. S., Steenbergen, J. N., & Sakoulas, G. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70200-2 · Cited by 130
Daum, R. S., Gupta, S., Sabbagh, R., & Milewski, W. M. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.5.1066 · Cited by 130
Vancomycin Resistance VanS/VanR Two-Component Systems
Hong, H., Hutchings, M. I., & Buttner, M. J. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78885-2_14 · Cited by 129
Hafer, C. A., Lin, Y., Kornblum, J. S., Lowy, F. D., & Uhlemann, A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01139-12 · Cited by 127
Reversion of the Glycopeptide Resistance Phenotype in Staphylococcus aureus Clinical Isolates
Boyle‐Vavra, S., Berke, S. K., Lee, J. C., & Daum, R. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.272-277.2000 · Cited by 126
Vancomycin Susceptibility within Methicillin-resistantStaphylococcus aureusLineages
Howe, R. A., Monk, A. B., Wootton, M., Walsh, T. R., & Enright, M. C. (2004) · Emerging infectious diseases · doi:10.3201/eid1005.030556 · Cited by 122
Howden, B. P., Smith, D. J., Mansell, A. S., Johnson, P. D. R., Ward, P. B., Stinear, T. P., & Davies, J. K. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-39 · Cited by 121
Boyle‐Vavra, S., Labischinski, H., Ebert, C. C., Kerstin Ehlert, B., & Daum, R. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.280-287.2001 · Cited by 118
Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002505 · Cited by 116
Horne, K., Howden, B. P., Grabsch, E. A., Graham, M., Ward, P. B., Xie, S., Mayall, B. C., Johnson, P. D. R., & Grayson, M. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01365-08 · Cited by 116
Pereira, P. M., Filipe, S. R., Tomasz, A., & Pinho, M. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00431-07 · Cited by 113
Critchley, I. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg130 · Cited by 113
Severin, A. I., Tabei, K., Tenover, F. C., Chung, M., Clarke, N., & Tomasz, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309593200 · Cited by 107
Matsuo, M., Hishinuma, T., Katayama, Y., Cui, L., Kapi, M., & Hiramatsu, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00398-11 · Cited by 107
Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States
Limbago, B. M., Kallen, A. J., Zhu, W., Eggers, P., McDougal, L. K., & Albrecht, V. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02187-13 · Cited by 101
Zhang, S., Sun, X., Chang, W., Dai, Y., & Ma, X. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136082 · Cited by 99
Studies on the mode of action of vancomycin
Reynolds, P. E. (1961) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(61)90698-9 · Cited by 99
Cantón, R., Loza, E., Morosini, M. I., & Baquero, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf811 · Cited by 92
Barber, K. E., Ireland, C. E., Bukavyn, N., & Rybak, M. J. (2014) · Infectious Diseases and Therapy · doi:10.1007/s40121-014-0023-0 · Cited by 88
Trotonda, M. P., Xiong, Y.-Q., Memmi, G., Bayer, A. S., & Cheung, A. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/595740 · Cited by 88
Boyle‐Vavra, S., Carey, R. B., & Daum, R. S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.5.617 · Cited by 88
Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Kerstin Ehlert, B., Labischinski, H., & Wilkinson, B. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3749-3757.2004 · Cited by 83
Matsuo, M., Cui, L., Kim, J., & Hiramatsu, K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-13 · Cited by 83
Diagnosis and management of Staphylococcus aureus bacteraemia
MITCHELL, D. H., & Howden, B. P. (2005) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2005.00977.x · Cited by 79
Renzoni, A., Andrey, D. O., Jousselin, A., Barras, C., Monod, A., Vaudaux, P. E., Lew, D., & Kelley, W. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021577 · Cited by 78
Finan, J. E., Archer, G. L., Pucci, M. J., & Climo, M. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3070-3075.2001 · Cited by 77
First Report on Vancomycin-Resistant Staphylococcus aureus in Bovine and Caprine Milk
Bhattacharyya, D., Banerjee, J., Bandyopadhyay, S., Mondal, B., Nanda, P. K., Samanta, I., Mahanti, A., Das, A. K., Das, G., Dandapat, P., et al. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0330 · Cited by 76
Seybold, U., Halvosa, J. S., White, N., Voris, V., Ray, S. M., & Blumberg, H. M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3161 · Cited by 73
Schulthess, B., Meier, S., Homerová, D., Goerke, C., Wolz, C., Kormanec, J., Berger‐Bächi, B., & Bischoff, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01255-08 · Cited by 72
McCallum, N., Karaüzüm, H., Getzmann, R., Bischoff, M., Majcherczyk, P. A., Berger‐Bächi, B., & Landmann, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00073-06 · Cited by 72
Ortwine, J. K., Werth, B. J., Sakoulas, G., & Rybak, M. J. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2013.10.002 · Cited by 69
Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus
Ruzin, A. V., Severin, A. I., Moghazeh, S. L., Étienne, J., Bradford, P. A., Projan, S. J., & Shlaes, D. M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00028-x · Cited by 69
Reversible Antibiotic Tolerance Induced in Staphylococcus aureus by Concurrent Drug Exposure
Haaber, J., Friberg, C., McCreary, M., Lin, R., Cohen, S. N., & Ingmer, H. (2015) · mBio · doi:10.1128/mbio.02268-14 · Cited by 69
Staphylococcus aureus infective endocarditis: diagnosis and management guidelines
Murray, R. J. (2005) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2005.00978.x · Cited by 68
Inducible carboxypeptidase activity in vancomycin-resistant enterococci
Gutmann, L., Billot-Klein, D., Al-Obeid, S., Klare, I., Francoual, S., Collatz, E., & van HEIJENOORT, J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.77 · Cited by 67
Vaudaux, P. E., Francois, P., Berger-Bächi, B., & Lew, D. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.163 · Cited by 66
McEvoy, C. R. E., Tsuji, B. T., Gao, W., Seemann, T., Porter, J. L., Doig, K., Ngo, D. T., Howden, B. P., & Stinear, T. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00279-13 · Cited by 64
Jenkins, T. C., McCollister, B. D., Sharma, R., McFann, K., Madinger, N. E., Barron, M. A., Bessesen, M. T., Price, C. S., & Burman, W. J. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/595963 · Cited by 59
Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue
Roberts, S., & Chambers, S. T. (2005) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2005.00983.x · Cited by 58
Renzoni, A., Barras, C., François, P., Charbonnier, Y., Huggler, E., Garzoni, C., Kelley, W. L., Majcherczyk, P. A., Schrenzel, J., Lew, D. P., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-06 · Cited by 58
Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient
Hageman, J. C., Pegues, D. A., Jepson, C., Bell, R. L., Guinan, M. E., Ward, K. W., Cohen, M. D., Hindler, J. A., Tenover, F. C., McAllister, S. K., et al. (2001) · Emerging infectious diseases · doi:10.3201/eid0706.010618 · Cited by 55
Roch, M., Clair, P., Renzoni, A., Reverdy, M. E., Dauwalder, O., Bes, M., Martra, A., Freydière, A.-M., Laurent, F. J., Reix, P., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02574-14 · Cited by 53
Boyle‐Vavra, S., Challapalli, M., & Daum, R. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.2036-2039.2003 · Cited by 48
Vidaillac, C., Gardete, S., Tewhey, R., Sakoulas, G., Kaatz, G. W., Rose, W. E., Tomasz, A., & Rybak, M. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit127 · Cited by 45
Genome sequencing in clinical microbiology
Chan, J. Z.-M., Pallen, M. J., Oppenheim, B. A., & Constantinidou, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2410 · Cited by 43
Claeys, K. C., Lagnf, A. M., Hallesy, J. A., Compton, M., Gravelin, A. L., Davis, S. L., & Rybak, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02388-15 · Cited by 43
Nelson, J. L., Rice, K. C., Slater, S. R., Fox, P. M., Archer, G. L., Bayles, K. W., Fey, P. D., Kreiswirth, B. N., & Somerville, G. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01057-06 · Cited by 41
Yoo, J. I., Kim, J. W., Kang, G. S., Kim, H. S., Yoo, J. S., & Lee, Y. S. (2013) · The Journal of Microbiology · doi:10.1007/s12275-013-3088-7 · Cited by 40
Berscheid, A., François, P., Strittmatter, A. W., Gottschalk, G., Schrenzel, J., Saß, P., & Bierbaum, G. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku297 · Cited by 40
Renzoni, A., Kelley, W. L., Barras, C., Monod, A., Huggler, E., François, P., Schrenzel, J., Studer, R., Vaudaux, P. E., & Lew, D. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01287-08 · Cited by 38
Chiu, C.-M., Lin, F.-M., Chang, T., Huang, W.-C., Liang, C., Yang, T., Wu, W.-Y., Yang, T.-L., Weng, S.-L., & Huang, H. (2014) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-4-1 · Cited by 20
Vancomycin failure in staphylococcal endocarditis
Jackson, M. A., & Hicks, R. A. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198708000-00011 · Cited by 18
Manquat, G., Croizé, J., Stahl, J. ‐., Meyran, M., Hirtz, P., & Micoud, M. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.6.731 · Cited by 16
Muthaiyan, A., Jayaswal, R. K., & Wilkinson, B. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.623-625.2004 · Cited by 12
Reduced vancomycin susceptibility in porcine ST9 MRSA isolates
Kwok, G. M. L., O'Donoghue, M. M., Doddangoudar, V. C., Ho, J., & Boost, M. V. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00316 · Cited by 9
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Comprehensive review of antimicrobial activities of plant flavonoids
Górniak, I., Bartoszewski, R., & Króliczewski, J. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-018-9591-z · Cited by 1,195
Cong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527
Metadata
- Authors
- Appelbaum, P. C., & Bozdogan, B.
- Venue
- Clinics in Laboratory Medicine
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 24
- Issue
- 2
- Pages
- 381-402
- ISSN
- 0272-2712 (ISSN-L)
- OpenAlex
- W2043967124
- Cited by
- 485
- References
- 153
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.